Get Premium to unlock powerful stock data
Cytokinetics Inc logo

Cytokinetics Inc

$ 38.79 +0.14 (+0.36%) 10:08 PM EST
P/E:
At Loss
P/B:
28.54
Market Cap:
$ 3.32B
Enterprise V:
$ 3.02B
Volume:
1.42M
Avg Vol (2M):
902.49K
Also Trade In:
Volume:
1.42M
Market Cap $:
3.32B
PE Ratio:
At Loss
Avg Vol (2-Month):
902.49K
Enterprise Value $:
3.02B
PB Ratio:
28.54
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Cytokinetics Inc
NAICS : 325412 SIC : 2834
280 East Grand Avenue, South San Francisco, CA, USA, 94080
Description
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.
Name Current Vs Industry Vs History
Cash-To-Debt 1.89
Equity-to-Asset 0.14
Debt-to-Equity 2.77
Debt-to-EBITDA -1.45
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.57
Distress
Grey
Safe
Beneish M-Score -3.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.82
9-Day RSI 48.34
14-Day RSI 49.73
6-1 Month Momentum % -7.17
12-1 Month Momentum % 59.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.33
Quick Ratio 9.33
Cash Ratio 9.11
Days Sales Outstanding 73.79
Days Payable 33.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.7

Financials (Next Earnings Date:2022-08-05 Est.)

CYTK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CYTK

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 65.028
EPS (TTM) ($) -3.22
Beta 1.05
Volatility % 65.49
14-Day RSI 49.73
14-Day ATR ($) 2.734484
20-Day SMA ($) 38.456
12-1 Month Momentum % 59.64
52-Week Range ($) 17.72 - 47.9
Shares Outstanding (Mil) 85.65

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cytokinetics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More